·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of April 25, 2022

In the news: Proposed FDA ban on menthol cigarettes, USPSTF recommendations on low-dose aspirin regimens, youth suicides, Paxlovid and more.

Publications & Newsletters
·
7 Min Read

April 29, 2022: Advocacy Update other news

Helping children and families, patients with pain on the latest Advocacy Update other news.

Advocacy Update
Illustration depicting communication between physician and woman patient
·
8 Min Read

What doctors wish patients knew about COVID-19 vaccines and fertility

There has been widespread misinformation circulating about COVID-19 vaccination and fertility. Three physicians took time to provide clarity.

series
Infectious Diseases
What Doctors Wish Patients Knew™
·
1 Min Read

AMA statement on FDA’s proposed ban on menthol cigarettes

The AMA supports the FDA’s action to propose a ban on menthol-flavored cigarettes and remove these harmful products from the market.

Press Releases
Apr 28, 2022 ·
43 Min Read

AMA Advocacy Insights webinar series: Drug overdose epidemic

Watch the latest AMA Advocacy Insights webinar and download slides on the nation’s drug overdose epidemic—helping children and families, patients with pain.

series
Events
Advocacy Insights Webinar Series
·
11 Min Read

Mask mandates & FDA approves Remdesivir for kids under 12 with Andrea Garcia, JD, MPH [Podcast]

The AMA is leading the fight against the COVID-19 pandemic. Listen to podcast updates on how the AMA is fighting COVID-19 by discussing mask mandates and FDA approval of Remdesivir for kids under 12.

series
Infectious Diseases
AMA Update Podcast
·
11 Min Read

Mask mandates & FDA approves Remdesivir for kids under 12 with Andrea Garcia, JD, MPH

The AMA is leading the fight against the COVID-19 pandemic. See video updates on how the AMA is fighting COVID-19 by discussing mask mandates and FDA approval of Remdesivir for kids under 12.

series
Infectious Diseases
AMA Update
·
4 Min Read

AMA announces CPT update for COVID-19 booster candidates

Provisional CPT codes assigned to booster candidates from Pfizer and Sanofi-GSK.

Press Releases
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of April 18, 2022

In the news: Cardiovascular risk for patients with T2D, impact of latitude on MS severity, access to COVID-19 test-to-treat program and more.

Publications & Newsletters